This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AXLA Axcella Health (AXLA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisTrendsBuy This Stock About Axcella Health Stock (NASDAQ:AXLA) Get Axcella Health alerts:Sign Up Key Stats Today's Range$0.40▼$0.4050-Day Range$0.40▼$4.5852-Week Range$0.34▼$41.25VolumeN/AAverage Volume267,009 shsMarket Capitalization$1.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Read More Receive AXLA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Axcella Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AXLA Stock News HeadlinesBiotech layoffs 2023: In Q4, 11 companies laid off around 500 peopleDecember 27, 2023 | bizjournals.comYear in Review: Here are the top stories in Boston-area life sciences in 2023December 25, 2023 | bizjournals.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.July 19 at 1:00 AM | Profits Run (Ad)Axcella Health to closeDecember 5, 2023 | msn.comFlagship spinout Axcella collapses, leaving future of its long Covid drug uncertainDecember 5, 2023 | bizjournals.comAxcella Health Inc AXLANovember 7, 2023 | morningstar.comMAxcella Health (AXLA) Price Target Increased by 7971.00% to 15,870.09November 1, 2023 | msn.comPre-market Movers: RLMD, BROG, VSME, AXLA, NKE…September 29, 2023 | markets.businessinsider.comSee More Headlines AXLA Stock Analysis - Frequently Asked Questions How were Axcella Health's earnings last quarter? Axcella Health Inc. (NASDAQ:AXLA) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($10.25) earnings per share for the quarter, beating analysts' consensus estimates of ($11.25) by $1.00. When did Axcella Health's stock split? Axcella Health shares reverse split on the morning of Tuesday, September 19th 2023.The 1-25 reverse split was announced on Thursday, September 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. When did Axcella Health IPO? Axcella Health (AXLA) raised $76 million in an IPO on Thursday, May 9th 2019. The company issued 3,600,000 shares at a price of $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO. What other stocks do shareholders of Axcella Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Axcella Health investors own include Predictive Oncology (POAI), Meta Platforms (META), NVIDIA (NVDA), Ford Motor (F), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT). Company Calendar Last Earnings11/10/2021Today7/19/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:AXLA CIK1633070 Webwww.axcellahealth.com Phone(857) 320-2200Fax617-441-6243Employees11Year Founded2010Profitability EPS (Trailing Twelve Months)($19.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$81.19 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-259.91% Debt Debt-to-Equity RatioN/A Current Ratio0.80 Quick Ratio0.80 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.42 per share Price / Book0.28Miscellaneous Outstanding Shares2,950,000Free Float2,883,000Market Cap$1.18 million OptionableNo Data Beta0.46 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:AXLA) was last updated on 7/19/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredOil is settling in yuan now - here's what that means for goldSaudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axcella Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axcella Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
